论文信息 - Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402). - 字舞流文

Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402).

E. Espinosa | M. Redrado | D. Rodríguez-Abreu | J. Piulats | R. López Castro | T. Curiel | M. Gomà | A. Rullán | L. de la Cruz Merino | A. Berrocal-Jaime | S. Martín-Algarra | A. Calvo González | M. Varela | L. Alonso Carrión | S. Martı́n-Algarra | R. López Castro